1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napthtalèn-1-yl) urées comme inhibiteurs de la p38 MAP kinase

• 收藏
• 分享

专利权人:

Respivert Limited

发明人:

申请号：

EP11183688.8

公开号：

EP2578582A1

申请日:

2011.10.03

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

There are provided compounds of formula (I) which are inhibitors of the family of p38 mitogen-activated protein kinase enzymes, and to their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/